Sort   by:  
 Page size 
UnknownPercutaneous closure of an iatrogenic right ventricular perforation with an angio-seal vascular closure device: a case report.
Not available
S-EPMC7649447 | biostudies-literature
UnknownNondominant Right Coronary Artery Occlusion: Small Vessel, Dramatic Sequelae.
Not available
S-EPMC8853955 | biostudies-literature
UnknownTen-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials.
Not available
S-EPMC9936252 | biostudies-literature
UnknownDerivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis.
Not available
S-EPMC10068863 | biostudies-literature
UnknownTarget and non-target vessel related events at 10 years post percutaneous coronary intervention.
Not available
S-EPMC9242894 | biostudies-literature
UnknownTen-Year Clinical Outcomes of Biodegradable Versus Durable Polymer New-Generation Drug-Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus.
Not available
S-EPMC8477883 | biostudies-literature
UnknownTen-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus : Results of the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol- and Zotarolimus-Eluting Stents (ISAR-TEST 5) trial.
Not available
S-EPMC8484170 | biostudies-literature
UnknownPolyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses.
Not available
S-EPMC7772752 | biostudies-literature
UnknownTicagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial.
Not available
S-EPMC8246339 | biostudies-literature
UnknownAn intranasal adjuvanted, recombinant influenza A/H5 vaccine primes against diverse H5N1 clades: a phase I trial.
Not available
S-EPMC12592354 | biostudies-literature
Sort   by:  
 Page size